7/1/2009
 
Menu CYBERTESIS     
INICIO>>ALERTA
ALERTAS BIBLIOGRÁFICAS
 
 
 

Alimentary Pharmacology & Therapeutics
ISSN: 0269-2813
 

 
  VOLUMEN 23 May, 2006 N° 10  
 
     


 

The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.

 

 


 

Efficacy and safety of bisacodyl in the acute treatment of constipation: a double-blind, randomized, placebo-controlled study.
Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA.

 

 



 

Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease.
Gunaratnam NT, Jessup TP, Inadomi J, Lascewski DP.

 

 


 

Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study.
Holm K, Maki M, Vuolteenaho N, Mustalahti K, Ashorn M, Ruuska T, Kaukinen K.

 

 

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
D'Inca R, Annese V, di Leo V, Latiano A, Quaino V, Abazia C, Vettorato MG, Sturniolo GC.
 

 

Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N.

 

 

Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
Creed TJ, Probert CS, Norman MN, Moorghen M, Shepherd NA, Hearing SD, Dayan CM; THE BASBUC INVESTIGATORS.

 

 

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
Miner PB Jr, Geary RS, Matson J, Chuang E, Xia S, Baker BF, Wedel MK.

 

A Phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
van Deventer SJ, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB Jr.

 

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
Miner PB Jr, Wedel MK, Xia S, Baker BF.

 

Review article: oesophageal spasm - diagnosis and management.
Tutuian R, Castell DO.

 

 

Review article: uncomplicated diverticular disease of the colon.
Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G.